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As the number of vascular procedures increases in
our aging population, reoperations constitute an
increasing proportion of vascular surgery practice.
This is particularly true of operations on the common
femoral artery (CFA), as this operative site is common
to operations for both aortoiliac and femoropopliteal
aneurysmal and occlusive disease. Despite the fre-
quency with which reoperations on the CFA are
required, there is no consensus regarding optimal
management. It is occasionally possible to avoid the
CFA by using the previously unoperated proximal
external iliac or distal superficial femoral artery (SFA)
or deep femoral artery (DFA) as an alternate site of
anastomosis.1,2 However, when disease in the CFA
itself must be addressed, bypass techniques frequently
do not suffice. This is true when there is severe occlu-
sive disease in the CFA as well as when endarterecto-
my and/or patch grafts and/or anastomoses of mul-
tiple proximal and/or distal bypass grafts have pro-
duced a markedly enlarged and distorted common
femoral complex, a condition referred to in this report
as “anastomotic dilation” (Fig. 1). 
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Purpose: This report details our experience with common femoral artery resection and
Dacron interposition grafting in the management of vascular reoperations involving the
common femoral artery.
Design: Retrospective review.
Setting: University teaching hospital.
Subjects: Consecutive reoperative patients who had common femoral artery interposition
grafting for arteriosclerotic occlusive disease from 1986 to 1997.
Interventions: Common femoral artery resection and interposition grafting.
Main outcome measures: Operative morbidity and mortality rates and long-term patency,
limb salvage, patient survival, freedom-from-graft-infection, and freedom-from-reoper-
ation rates.
Results: Ninety-nine common femoral arteries (16 bilateral) were resected and replaced
with Dacron interposition grafts in 83 patients (50 male, 33 female; mean age, 65 years)
who had had 237 previous ipsilateral common femoral artery operations (mean, 2.4
operations; range, 1-9 operations). Simultaneous infrainguinal bypass grafts were per-
formed in 52 operations (53%), and 60 operations (61%) were performed in patients
who had had previous ipsilateral proximal bypass grafts. Operative mortality was 2%,
with a 14% rate of perioperative wound complications. Mean follow-up time was 22
months. One- and 3-year assisted primary patency rates for the interposition grafts were
90% and 77%, respectively. Both 1- and 3-year life-table–determined limb salvage rates
were 95%. One- and 3-year life-table–determined freedom-from-reoperation rates were
74% and 43%, respectively. One- and 3-year life-table–determined freedom-from-infec-
tion rates were 99% and 92%, respectively. One- and 3-year life-table–determined sur-
vival rates were 82% and 73%, respectively.
Conclusions: Common femoral artery resection and Dacron interposition grafting are
safe, and they obviate many difficulties associated with reoperative common femoral
artery surgery with satisfactory long-term results. (J Vasc Surg 1998;28:37-44)
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The combination of resection of the CFA/old
graft anastomotic complex and interposition Dacron
grafting is a straightforward approach to the surgical
problems inherent in reoperation on the CFA. The
technique is applicable to both recurrent occlusive
disease and to anastomotic dilation and is well suit-
ed to combination with proximal inflow and distal
outflow bypass grafts. A description of the operative
technique and of results with this operation during
the past 10 years forms the basis for this report.
METHODS
Technique
CFA interposition grafting was performed both in
patients with severe recurrent occlusive disease in the
CFA and in patients with anastomotic dilations in
CFAs that were abnormally enlarged as a consequence
of previous endarterectomy, patch grafting, or previ-
ous graft anastomoses (Fig. 1) . The initial step in the
CFA procedure was complete dissection of the CFA
and all previous attached grafts. Dissection extended
from the distal external iliac artery (exposed by divi-
sion of the inguinal ligament) to complete exposure
of sufficient distal uninvolved DFA to permit uncom-
promised anastomosis of the interposition graft and
any required distal bypass grafts. Because all patients
had undergone prior CFA procedures, the dissection
involved was frequently tedious. Procedures were per-
formed most often by multiple operating teams, each
consisting of a senior faculty surgeon and a resident
trainee. Operative time was minimized by allowing
one operating team to concentrate entirely on the
CFA portion of the procedure while others complet-
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Fig. 1. Anastomotic dilation of reoperated common
femoral artery with previous graft anastomoses.
Fig. 2. Dacron interposition graft from external iliac to
profunda femoris arteries.
ed the other portions. Once complete dissection was
achieved, the entire diseased CFA, proximal portions
of all previous bypass grafts, and the proximal portion
of the occluded SFA were excised.
Interposition grafts were constructed of Dacron
(diameter, 8 mm). The proximal anastomosis was
end-to-end to the external iliac artery if it was patent
or to existing or newly constructed inflow bypass con-
duits if the external iliac artery was occluded. Distally
the interposition graft was usually anastomosed end-
to-end to the DFA; occasionally it was anastomosed
to the femoral bifurcation if the SFA remained patent
(Fig. 2). When required, distal bypass grafts were
anastomosed end-to-side to the DFA (or the SFA)
distal to the distal anastomosis of the Dacron interpo-
sition graft through use of techniques previously
described.3-6 (Fig. 3). The inguinal ligament was
repaired during closure to prevent later hernia.
Patency of vascular reconstructions was con-
firmed intraoperatively by means of continuous
wave Doppler to examine the distal profunda, the
ankle, or both. Follow-up examinations were per-
formed every 3 months for the first year and then
every 6 months for life. Duplex scanning and
ankle/brachial pressure ratios were used to evalu-
ate for graft patency and the development of
pseudoaneurysm during follow-up. Suspected
occlusions and pseudoaneurysms were confirmed
by arteriography.
Data review
All patients who underwent reoperative CFA
surgery that included resection and interposition
graft replacement from March 1986 through May
1997 were identified from the computerized vascular
registry at the Oregon Health Sciences University.
Patient records were reviewed for demographics,
associated risk factors, presenting symptoms, and
number of prior ipsilateral CFA operations (inflow
procedures and/or outflow procedures).
Operative findings were noted, including nature
of the pathologic condition of the resected CFA,
site of proximal and distal anastomoses of the inter-
position graft, conduit used, and details of any
adjunctive distal bypasses. Perioperative morbidity,
mortality, and life-table–determined graft patency
were recorded. Patient outcome was assessed by
life-table–determined freedom-from-reoperation,
freedom-from-infection, limb salvage, and survival
rates. The methods used were in accordance with
the reporting standards adopted by the joint vascu-
lar societies for treatment of lower extremity
ischemia.7
RESULTS
Patients
From 1986 to 1997, 83 reoperative patients (50
male (60%) and 33 female (40%); mean age, 65 years;
age range, 33 to 86 years) underwent CFA resection
and interposition Dacron grafting. Associated risk
factors are presented in Table I. All operated limbs
had undergone prior ipsilateral vascular procedures
involving the CFA; 25 limbs (26%) had undergone
aortofemoral and/or axillofemoral inflow proce-
dures, 39 limbs (39%) had undergone infrainguinal
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Fig. 3. Reversed saphenous vein graft originating from
profunda femoris artery distal to Dacron interposition
graft.
outflow procedures, and 35 limbs (35%) had under-
gone both inflow and outflow procedures. Operative
indications included rest pain/ulceration (63%),
claudication (11%), graft stenosis (7%), and groin
mass (19%).
Procedures
Ninety-nine CFA resections and Dacron interpo-
sition grafts (16 bilateral) were performed in the 83
patients. Fifty-nine resections (60%) were for CFA
anastomotic dilation, and 40 resections (40%) were
for CFA obliterative occlusive disease/scarring.
Thirty-nine grafts (39%) originated from the exter-
nal iliac artery and 60 (61%) from inflow grafts.
Most distal anastomoses were to the DFA (79 anas-
tomoses; 80%), with the remainder (20 anasto-
moses; 20%) to the femoral bifurcation, to existing
grafts, or to a combination of these.
Fifty-two distal bypass grafts (10 to popliteal, 42
to infrapopliteal) were performed simultaneously
with the CFA interposition grafts. Most of these (48
grafts; 92%) originated from the DFA distal to the
interposition graft. The remainder (4 grafts; 8%)
originated directly from the interposition grafts or
existing bypass grafts. Distal bypass conduits includ-
ed 24 saphenous veins (46%), 22 alternate veins
(42%), and 6 prosthetic grafts (12%).
There were two perioperative deaths from
myocardial infarction. Major morbidity data are pre-
sented in Table II. The median hospital stay of 8
days (range, 3 to 43 days) reflected not only wound
complications (14%) but also the fact that many
(56%) of the patients additionally had distal bypass-
es placed or revised. Mean follow-up time was 22
months. Life-table–determined results for assisted
primary patency, freedom from infection, freedom
from any reoperation, limb salvage, and patient sur-
vival are presented in Table III. Of note is the find-
ing that despite the high incidence of reoperation,
only 44% of reoperations involved the common
femoral interposition graft and 56% involved revi-
sion or placement of a distal bypass.
Four interposition grafts became infected and
required removal; three of the four were placed in
heavily scarred groins with a mean of six prior pro-
cedures. Two patients had active foot infection at
the time of graft placement. One patient had
undergone previous pelvic radiation for prostate
cancer, and his groin incision did not heal. One
patient who had undergone nine previous CFA
procedures had pelvic sepsis from colon ischemia.
Two of the infected Dacron interposition grafts
were replaced with autogenous conduit; one limb
was salvaged, but subsequent distal bypass occlu-
sion in the other required above-the-knee amputa-
tion. The remaining two Dacron interposition graft
infections were in patients with existing inflow
prostheses; these patients required both interposi-
tion graft and aortofemoral/axillofemoral graft
limb removal without autogenous replacement,
with resultant limb loss.
DISCUSSION
The available data regarding complicated reopera-
tive CFA surgery are modest. A few reports describe
management of a handful of isolated CFA occlu-
sions8,9; additional reports describe CFA reconstruc-
tion for femoral aneurysm.10,11 However, most of
these cases were not reoperative. Results of reopera-
tive procedures involving the CFA have been pub-
lished as small subsets of larger series describing pro-
fundaplasty.12,13 Malone et al.14 described 50 patients
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Table II. Major morbidity associated with com-
mon femoral artery resection and interposition
grafting
Complications No. patients (%)
Wound 14 (14)
Pulmonary failure 2 (2)
Myocardial infarction 4 (4)
Colon ischemia 1 (1)
Graft infection 4 (4)
Table III. Life-table–determined results
1 yr (%) 3 yr (%)
Assisted primary patency 90 77
Freedom from infection 99 92
Freedom from any reoperation 74 43
Limb salvage 95 95
Patient survival 82 73
Table I. Risk factors in patients undergoing com-
mon femoral artery interposition grafting for reop-
erative groin surgery
Risk factor No. patients (%)
Hypertension 54 (63)
Tobacco use 74 (89)
Diabetes mellitus 21 (24)
Renal insufficiency 5 (6)
Coronary artery disease 44 (53)
Hypercoaguable state 5 (6)
with 67 aortofemoral graft limb occlusions managed
by retrograde graft thrombectomy and profundaplas-
ty with autogenous or Dacron patch. Most of these
patients underwent CFA endarterectomy as part of
the procedure. There were no operative deaths.
Primary patency at 36 months was a disappointing
2%. DePalma et al.15 described seven reoperative
groin procedures in which autogenous bypass from a
previous failed inflow graft to the distal profunda
femoris without CFA excision was used. During
short-term follow-up (mean, <1 year) one limb was
lost to amputation after graft failure. Reports of
femoral pseudoaneurysm repair represent the largest
amount of available data on CFA reoperations.16-19
The most frequently performed procedure in these
series was aneurysmectomy with interposition graft to
the CFA or DFA. Operative mortality rates ranged
from 3% to 8%, and recurrence in these studies with
follow-up was 6% to 10% at 2 to 3 years.
Results in two large series involving use of the
DFA as an inflow source for autogenous distal bypass
have been published.20,21 The primary patency rate
was 77% at 5 years in the larger of these studies.20
The advantage of this technique is avoidance of reop-
eration on the densely scarred CFA. Although this
clearly is an advantage, many patients who have had
multiple previous CFA operations have markedly
enlarged arterial complexes consisting of CFAs and
previous patch grafts and/or anastomoses of previous
bypass grafts. The presence of considerable intralu-
minal thrombus in many of these anastomotic dila-
tions leads us to conclude that this may be part of the
problem in the production of recurrent occlusions.
For these patients, the CFA complex must be
approached directly. CFA resection and interposition
grafting is our choice for reconstruction.
Complete dissection of the CFA and all previous
bypass graft origins is the technical step that allows
the performance of excision and interposition graft-
ing. This procedure is often tedious and is frequent-
ly associated with significant blood loss. When the
CFA reoperation must be combined with other pro-
cedures, such as proximal and distal bypass grafting,
use of multiple operating teams allows completion of
these complex procedures within reasonable operat-
ing times.
Although this reported experience suffers from
lack of a control group of patients with unresected
anastomotic dilations, our (unreported) past experi-
ence with loss of distal reconstructions from throm-
boembolic complications convinced us to adopt this
more aggressive approach. We have no historic con-
trols, and we could not find reports in the literature
that were truly comparable to this complex assort-
ment of cases. The 73% 3-year survival rate reported
in this series is better than previous purely limb-sal-
vage rates reported from our institution.22,23 In 20%
of the cases in the current series the procedures were
performed to treat aneurysmal disease; 7% of the
procedures were precipitated by graft surveillance
findings. The patency and limb salvage results of the
operations reported in this series compare very
favorably with those described previously for reoper-
ative femoral artery procedures.16,17,19 At 3- to 4-
year follow-up in these studies, amputation rates
ranged from 5% to 7% and the patency rate was
approximately 80% to 85%.
The graft configuration chosen for these opera-
tions included origin of distal bypass grafts from the
DFA (or rarely SFA) distal to the distal anastomosis
of the Dacron interposition grafts, rather than
directly from the interposition grafts. This configu-
ration has several advantages. The most important is
that distal origin of distal bypass grafts minimizes the
required length of autogenous vein—always a con-
sideration in distal bypass surgery, especially in reop-
erative cases (more than one half of the distal vein
grafts required in the present series were alternate
veins). Separating the CFA interposition graft from
the distal autogenous bypass graft means that either
can be reoperated on without exposing the other;
this minimizes the risk of prosthetic infection if
reoperation is required to treat vein graft lesions dis-
covered by vascular laboratory surveillance—a situa-
tion that in our experience occurs in 30% of alternate
vein grafts.4 Finally, we have observed no differences
in patency between distal bypasses originating from
the interposition graft and those originating from
the profunda, though the numbers are small.
However, separating the graft has the advantage that
occlusion of the inflow does not automatically doom
the distal bypass, some of which we have observed to
maintain patency through collateral flow.
Use of prosthetic interposition grafts obviously
raises concern about graft infection. The 4% inci-
dence in this series of multiple operated groins is not
significantly different from the 2% to 2.5% rate of
infection reported for all cases of prosthetic
aortofemoral or femoropopliteal grafts.24-26 In only
15% of the operated limbs in the present series did
the patient not already have prosthetic material in his
groin as part of previous vascular reconstructions
prior to CFA excision and Dacron interposition
grafting; thus the prosthetic interposition graft was
only rarely the initial prosthetic in the patient.
Reoperative CFA surgery is a commonly encoun-
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Dr. P Michael McCart (Orange, Calif.). Dr. Nehler
presents a ten-year retrospective review of the University
of Oregon experience with common femoral artery resec-
tion and interposition Dacron grafting. This technique
was adopted to simplify the reoperative repair of severely
scarred common femoral arteries, often with iatrogenic
aneurysms after previous patch grafting or bypass graft
anastomoses. The proximal anastomosis was either from
the external iliac artery or an inflow graft. The distal anas-
tomosis was usually end-to-end to the distal common
femoral artery but on occasion was end-to-side to the
superficial femoral or deep femoral arteries. Of the com-
mon femoral artery interposition grafts, 50% included dis-
tal bypass grafts, usually originating from the deep femoral
DISCUSSION
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tered but infrequently studied clinical entity. The
increase in reoperative procedures in the modern
vascular practice makes this problem worthy of
examination. We conclude that resection of the
CFA/old graft complex with Dacron interposition
grafting is a satisfactory approach that yields accept-
able results in this difficult patient population.
REFERENCES
1. Veith FJ, Gupta SK, Samson RH, Flores SW, Jenko G, Scher
LA. Superficial femoral and popliteal arteries as inflow sites
for distal bypasses. Surgery 1981;90:980-90.
2. Nunez AA, Veith FJ, Collier P, Ascer E, Flores SW, Gupta
SK. Direct approaches to the distal portions of the profunda
femoris artery for limb salvage bypasses. J Vasc Surg
1988;8:576-81.
3. Masser PA, Taylor LM Jr, Moneta GL, Porter JM. Technique
of reversed bypass for lower extremity ischemia. Ann Vasc
Surg 1996;10:190-200.
4. Gentile AT, Lee RW, Moneta GL, Taylor LM Jr, Edwards
JM, Porter JM. Results of bypasses to popliteal and tibial
arteries with alternative sources of autogenous vein. J Vasc
Surg 1996;23:272-80.
5. Nehler MR, Moneta GL, Yeager RA, Edwards JM, Taylor
LM Jr, Porter JM. Surgical treatment of threatened reversed
infrainguinal vein grafts. J Vasc Surg 1994;20:558-65.
6. DeFrang RD, Edwards JM, Moneta GL, Yeager RA, Taylor
LM Jr, Porter JM. Repeat leg bypass after multiple bypass
failures. J Vasc Surg 1994;19:268-77. 
7. Rutherford RB, Flanigan DP, Gupta SK, Johnston KW,
Karmondy A, Whittemore AD, Baker JD, Ernst CB.
Suggested reporting standards for reports dealing with lower
extremity ischemia. J Vasc Surg 1986;4:80-94.
8. Springhorn ME, Kinney M, Littooy FN, Saletta C, Greisler
HP. Inflow atherosclerotic disease localized to the common
femoral artery: treatment and outcome. Ann Vasc Surg
1991;5:234-40.
9. McGovern PJ Jr, Stark KR, Kaufman JL, Rosenberg N.
Management of common femoral artery occlusion: a report
of 10 cases. J Cardiovasc Surg (Torino) 1987;28:38-41.
10. Graham LM, Zelenock GB, Whitehouse WM Jr, Erlandson
EE, Dent TL, Lindenauer SM, Stanley JC. Clinical signifi-
cance of atherosclerotic femoral artery aneurysms. Arch Surg
1980;115:502-7.
11. Cutler BS, Darling RC. Surgical management of atheroscle-
rotic femoral aneurysms. Surgery 1973;74:764-73.
12. Edwards WH, Jenkins JM, Mulherin JL Jr, Martin RS,
Edwards WH Jr. Extended profundaplasty to minimize pelvic
and distal tissue loss. Ann Surg 1990;211:694-702.
13. Taylor LM Jr, Baur GM, Eidemiller LR, Porter JM. Extended
profundaplasty: indications and techniques with results in 46
procedures. Am J Surg 1981;141:539-42.
14. Malone JM, Goldstone J, Moore WS. Autogenous profun-
daplasty: the key to long-term patency in secondary repair of
aortofemoral graft occlusion. Ann Surg 1978;188:817-23.
15. DePalma RG, Malgieri JJ, Rhodes RS, Clowes AW. Profunda
femoris bypass for secondary revascularization. Surgery,
Gynocology, Obstetrics 1980;151:387-90.
16. Schellack J, Salam A, Abouzeid MA, Smith RB III, Stewart
MT, Perdue GD. Femoral anastomotic aneurysms: a contin-
uing challenge. J Vasc Surg 1987;6:308-17.
17. Di Marzo L, Strandness EL, Schultz RD, Feldhaus RJ.
Reoperation for femoral anastomotic false aneurysm: a 15
year experience. Ann Surg 1987;206:168-72.
18. Youkey JR, Clagett GP, Rich NM, Brigham RA, Orecchia
PM, Salander JM. Femoral anastomotic false aneurysms: an
11-year experience analyzed with a case control study. Ann
Surg 1984;199:703-9.
19. Nichols WK, Stanton M, Silver D, Keitzer WF. Anastomotic
aneurysms following lower extremity revascularization.
Surgery 1980;88:366-74.
20. Darling RC III, Shah DM, Chang BB, Lloyd WE, Leather
RP. Can the deep femoral artery be used reliably as an inflow
source for infrainguinal reconstruction?: long-term results in
563 procedures. J Vasc Surg 1994;20:889-95.
21. Mills JL, Taylor SM, Fujitani RM. The role of the deep
femoral artery as an inflow site for infrainguinal revascular-
ization. J Vasc Surg 1993;416-23.
22. Yeager RA, Moneta GL, Taylor LM Jr, Hamre DW,
McConnell DB, Porter JM. Surgical management of severe
acute lower extremity ischemia. J Vasc Surg 1992;15:385-93.
23. Taylor LM Jr, Hamre DW, Dalman RL, Porter JM. Limb sal-
vage vs amputation for critical ischemia: the role of vascular
surgery. Arch Surg 1991:126:1251-8.
24. Lorentzen JE, Nielsen OM, Arendrup H, Kimose HH, Bille
S, Anderson J, et al. Vascular graft infection: an analysis of
sixty-two graft infections in 2411 consecutively implanted
synthetic vascular grafts. Surgery 1985;98:81-6.
25. Edwards WH Jr, Martin RS III, Jenkins JM, Edwards WH Sr,
Mulherin JL Jr. Primary graft infections. J Vasc Surg
1987;6:235-9.
26. Samson RH, Veith FJ, Janko GS, Gupta SK, Scher LA. A
modified classification and approach to the management of
infections involving peripheral arterial prosthetic grafts. J
Vasc Surg 1988;8:147-53.
Submitted Oct. 8, 1997; accepted Jan. 9, 1998.
artery. Patency was confirmed during surgery continuous
wave Doppler. Duplex scanning and ankle pressures were
used for long-term follow-up.
The authors conclude that resection of the common
femoral artery/old graft complex with Dacron interposi-
tion grafting is a satisfactory approach to the difficult prob-
lems often encountered with reoperations of the common
femoral artery. Although I have little experience with com-
mon femoral artery resection, except for the treatment of
aneurysms, I am intrigued with Dr. Nehler’s approach to
reoperation of the difficult femoral artery. The operation
seems more straightforward and hemodynamically sound
than re-endarterectomy and patch grafting. His results
compare favorably with those in the literature. The assisted
primary patency rate at 1 year is 90% and at 3 years is 77%.
The rate of freedom from any reoperation is 74% at 1 year
and 43% at 3 years. What is the actual primary patency rate?
Have you analyzed the reasons for reocclusion? What was
the status of the outflow vessels with late occlusion? Have
you compared the patency rates of this technique with the
standard methods of reendarterectomy and patch grafting?
Do you plan to compare your patency and infection rates
with Dacron with those of other graft materials such as
polytetrafluoroethylene? Was there any evidence of hyper-
coagulability in those patients who had recurrent occlusion
but no specific outflow obstruction?
In conclusion, I enjoyed this paper and commend the
authors for helping us further define the proper surgical
techniques for treatment of recurrent stenosis and other
problems encountered with reoperations of the common
femoral artery.
Dr. Mark R. Nehler. I thank Dr. McCart for his will-
ingness to review the manuscript and for his comments. I
will try to answer the questions.
The differences in numbers between the abstract and
manuscript reflected the time between the abstract sub-
mission and manuscript submission when we accrued
more patients and extended the follow-up.
I do not have primary patency data, but several cases
fell from the primary patency category because of reoper-
ations caused by recurrent pseudoaneurysms.
In analyzing the cause of the interposition graft occlu-
sions, almost all were caused by outflow problems. All of
these patients had occluded superficial femoral arteries.
Either the distal graft occluded with subsequent interposi-
tion graft occlusion, or the interposition graft was to the
distal profunda in patients with existing amputations. In
addition, there were several grafts that occluded in patients
with hypercoagulable states.
We did not compare our experience at the same time
with endarterectomy or other more traditional ways to
deal with the reoperative common femoral artery. As in
many technique reports, the technique is favored by some
of the staff surgeons more than others. However, there is
no control group.
We did not use polytetrafluoroethylene. We used
Dacron, but that is an issue of preference. I am not sure
that it makes a difference.
Dr. Kaj Johansen (Seattle, Wash.). This approach is
frankly attractive for the matted scarred reoperative groin
not uncommonly seen at referral centers. Yet, it seems that
generalizing this procedure to all reoperative groins may
be “too much of a good thing.”
Why not use a simpler approach of suprainguinal
extraperitoneal exposure of either the aortofemoral graft
limb or the external iliac artery, and another of the pro-
funda femoris artery in the upper thigh, and then just tun-
nel a graft between the two? Would you comment?
Dr. Nehler. I think that certainly you could exclude this
area just as you describe and that would eliminate the
potential for injury to the femoral nerve or the femoral
vein. The Oregon group tends to approach things directly
as a matter of style. Where you see disease, you go after it.
Dr. George Andros (Los Angeles, Calif.). I thank Dr.
Nehler for providing me with a copy of his manuscript. He
has asked me to comment because, unfortunately, we also
perform much reoperative surgery in the femoral region.
The Portland group has been a leader in teaching tech-
nical surgery to all vascular surgeons. They have shown that
axillofemoral bypass graft can become a standard operation
in selected instances, and they have been forceful in attack-
ing lower-extremity revascularization with autogenous veins.
When Portland speaks, I think we ought to listen.
Unfortunately, I have some difficulty with femoral artery
resection as a universal technique for repair of the previous-
ly operated femoral artery. Does every patient with a repeat
operation in the groin have femoral artery resection? I find it
difficult to accept that a patient who is first seen with a
pseudoaneurysm, with or without a distal femoropopliteal
bypass graft, would have such an extensive procedure. All
that is needed is an opening of the aneurysm, insertion of
three occlusion balloons, and reapplication of a distal exten-
sion graft. This seems to be a much easier approach to a
common femoral artery “iatrogenic aneurysm.” Where does
the simple pseudoaneurysm fit into your operative schema?
How do you select which patients get which opera-
tion? Are there any tests that can help us select the patients
who need an extensive resection like this and those who
do not? I believe you have not helped the patient if you
have excised his groin mass, but he is unable to flex his
thigh because of inadvertent injury to his femoral nerve.
We would probably be better off if we knew when to reex-
plore the groin and when to avoid it and perform a bypass
graft around the area.
I applaud your selection of the deep femoral artery as
an inflow site for a distal bypass graft. I believe that it is the
right approach. I am uncertain, however, why you proceed
with the femoropopliteal bypass graft at the same time.
Can you come back at a later time in a few days or weeks?
I know that you can marshal a battalion of surgeons to
attack every patient in Portland, but would it be best to
see if the revascularization in the groin were sufficient to
take care of the problem? Finally, what do you do when
you have inserted a synthetic graft in the groin for the
“iatrogenic aneurysm” and that new graft becomes infect-
ed? How do you deal with that patient?
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Dr. Nehler. I will try to answer your questions one at a
time. The small number of patients in this series that had
pseudoaneurysms were generally patients who had failed
more traditional approaches. In selecting patients for this
technique, a preoperative angiogram occasionally added to
the decision, but the majority of these decisions were
made at operation after examining the femoral artery.
A substantial amount of this is surgeon judgment and
being comfortable with this technique. Clearly, if you were
to look at our ten-year experience, there is more of this
technique done in the last 5 years than was done in the
first 5 years.
The second question asked why not do it at separate
operations. Well, now that I am at Colorado and operating
alone with the residents that may be something I do. It is
much work to dig out the reoperated groin and then take
arm veins for a distal bypass graft. That will ruin your
whole day. So, there could be something said for staging it.
We did many things at Oregon on the basis of man-
power. It allowed us to tackle these operations because you
could have two or three attending physicians in the room.
One physician could be taking an arm vein while another is
preparing the groin and the third is preparing the distal tar-
get. However, that is an unique feature of that institution.
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http://www.vascsurg.org
and hang on to your hat! You can scan back issues of the Journal of Vascular
Surgery, look up a colleague who is a member of most regional vascular societies,
review abstracts for upcoming vascular meetings, analyze a challenging “Case of
the Month,” and enjoy many other interesting features.
Don’t forget to visit the “Welcome” area for the latest information on navigat-
ing the site, and please register for your user name and password if you have not
already received these as a member of either The Society for Vascular Surgery or
the North American Chapter of the International Society for Cardiovascular
Surgery.
SEE YOU ON THE WEB!
Richard F. Kempczinski, MD
WebMaster
